Keywords: Gastrointestinal Infections; Geriatrics; Clostridioides difficile; Norovirus; Antimicrobial Stewardship; Immunosenescence

References

1. Prince MJ., et al. “The burden of disease in older people and implications for health policy and practice”. Lancet 9967 (2015): 549-562.
2. Chen WH., et al. “Vaccination in the elderly: an immunological perspective”. Trends in Immunology7 (2009): 351-359.
3. Magill SS., et al. “Multistate point-prevalence survey of health care-associated infections”. The New England Journal of Medicine13 (2014): 1198-1208.
4. Nikolich-Žugich J. “The twilight of immunity: emerging concepts in aging of the immune system”. Nature Immunology1 (2018): 10-19.
5. O’Toole PW and Jeffery IB. “Gut microbiota and aging”. Science 6265 (2015): 1214-1215.
6. Feldman F and Kalantar JS. “Gastrointestinal function in the elderly”. Gastroenterology Clinics of North America 3 (2009):435-444.
7. Gavazzi G and Krause KH. “Ageing and infection”. Lancet Infectious Disease11 (2002): 659-666.
8. Drekonja DM., et al. “Antimicrobial stewardship in outpatient settings: a systematic review”. Infection Control & Hospital Epidemiology 2 (2015): 142-152.
9. Montoya A and Mody L. “Common infections in nursing homes: a review of current issues and challenges”. Aging Health6 (2011): 889-899.
10. Mangoni AA and Jackson SHD. “Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications”. British Journal of Clinical Pharmacology1 (2004): 6-14.
11. Bavishi C and Dupont HL. “Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection”. Aliment Pharmacology Therapy11-12 (2011): 1269-1281.
12. Bharucha AE and Camilleri M. “Aging and gastrointestinal neuromuscular function”. Neurogastroenterology & Motility10 (2007):790-799.
13. Frasca D and Blomberg BB. “Aging affects human B cell responses”. Journal of Clinical Immunology3 (2011): 430-435.
14. Biagi E., et al. “Aging of the human metaorganism: the microbial counterpart”. Age (Dordr ) 34.1 (2012): 247-267.
15. Freedberg DE., et al. “Receipt of antibiotics and risk of Clostridium difficile in hospitalized patients. Infection Control & Hospital Epidemiology10 (2016): 1216-1221.
16. Meydani SN., et al. “Serum vitamin D and the risk of upper respiratory tract infection in older adults”. The American Journal of Clinical Nutrition6 (2005): 1277-1286.
17. Lessa FC., et al. “Burden of Clostridium difficile infection in the United States”. The New England Journal of Medicine9 (2015): 825-834.
18. Cornely OA., et al. “Treatment of first recurrence of Clostridium difficile infection: fidaxomicin vs vancomycin”. Clinical Infectious Diseases2 (2012): S154-161.
19. Lopman BA., et al. “The vast and varied global burden of norovirus: prospects for prevention and control”. PLoS Medicine4 (2016): e1001999.
20. Anderson EJ and Weber SG. “Rotavirus infection in adults”. Lancet Infectious Diseases2 (2004): 91-99.
21. Hohmann EL. “Nontyphoidal salmonellosis”. Clinical Infectious Diseases2 (2001): 263-269.
22. Moffatt CR and Musto J. “Campylobacteriosis in elderly patients: association with increased mortality and impact of age on antimicrobial resistance”. Journal of Clinical Microbiology11 (2013): 3569-3572.
23. Charlier C., et al. “Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study”. Lancet Infectious Diseases5 (2017): 510-519.
24. Hunter PR and Nichols G. “Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients”. Clinical Microbiology Review1 (2002): 145-154.
25. Bartlett JG. “Clinical practice. Antibiotic-associated diarrhea”. The New England Journal of Medicine5 (2002): 334-339.
26. Polage CR., et al. “Overdiagnosis of Clostridium difficile infection in the molecular test era”. JAMA Internal Medicine11 (2015): 1792-801.
27. High KP., et al. “Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities”. Clinical Infectious Diseases2 (2009): 149-171.
28. Rao K and Safdar N. “Fecal microbiota transplantation for the treatment of Clostridium difficile infection”. Journal of Hospital Medicine 1 (2016):56-61.
29. Maher RL., et al. “Clinical consequences of polypharmacy in elderly”. Expert Opinion on Drug Safety 1 (2014): 57-65.
30. Owens RC Jr and Ambrose PG. “Antimicrobial safety: focus on fluoroquinolones”. Clinical Infectious Diseases2 (2005): S144-157.
31. McDonald LC., et al. “Clinical practice guidelines for Clostridium difficile infection in adults and children”. Clinical Infectious Diseases7 (2018):e1-48.
32. Kelly CR., et al. “Fecal microbiota transplantation is effective, safe, and durable in treating recurrent Clostridioides difficile infection”. Gastroenterology1 (2021):196-198.
33. Nicolle LE. “Antimicrobial stewardship in long term care facilities: what is effective?” Antimicrobial Resistance and Infection Control 1 (2014):6.
34. van der Steen JT., et al. “White paper defining optimal palliative care in older people with dementia: a Delphi study”. Palliate Medicine3 (2014): 197-209.
35. Guh AY., et al. “Trends in U.S. burden of Clostridioides difficile infection and outcomes”. The New England Journal of Medicine14 (2020): 1320-1330.
36. Boyce JM and Pittet D. “Guideline for hand hygiene in health-care settings”. MMWR Recommendations and Reports RR-16 (2002):1-45.
37. van Buul LW., et al. “Antibiotic use and resistance in long term care facilities”. Journal of the American Medical Directors Association 6 (2012): 568.e1-13.
38. Dening KH., et al. “Advance care planning for people with dementia: a review”. International Psychogeriatry10 (2011):1535-1551.
39. Mody L., et al. “A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial”. JAMA Internal Medicine5 (2015): 714-723.
40. Atmar RL., et al. “Norovirus vaccine against experimental human Norwalk Virus illness”. The New England Journal of Medicine23 (2011):2178-2187.
41. Pilotto A., et al. “Comprehensive geriatric assessment in hospital and long-term care: evidence and challenges”. Age Ageing3 (2017): 442-9.
42. Muscedere J., et al. “The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis”. Intensive Care Medicine8 (2017):1105-22.
43. “Bacterial Lipopolysaccharides and Neuron Toxicity in Neurodegenerative Diseases”. Neurology Research and Surgery1 (2018): 1-3.
44. “Antibiotic Resistance Involves Antimicrobial Inactivation in Global Communities”. Scholarena Journal of Pharmacy and Pharmacology 2 (2017): 102.
45. Sharma A and IJ Martins. “The role of Microbiota in the pathogenesis of Alzheimer’s disease”. Acta Scientific Nutritional Health7 (2023): 108-118.

Citation

Citation: Taranpreet Kaur., et al. “Gastrointestinal Infections in the Geriatric Population: Diagnostic and Therapeutic Challenges".Acta Scientific Gastrointestinal Disorders 8.11 (2025): 34-42.

Copyright

Copyright: © 2025 Taranpreet Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.